| In Silico Testing of Hypotheses for the Effect of Smoking on Somatic Evolution in the Healthy Human Lung |
Sam Janes |
University College London |
PLCO |
Jun 22, 2023 |
PLCO-1258 |
| Analyze the effectiveness of CA-125 to detect ovarian and non-ovarian cancer. |
Joel Sokol |
Georgia Institute of Technology |
PLCO |
Jun 13, 2023 |
PLCO-1253 |
| Detection of frameshift mutations in microsatellite instable colorectal cancer in the PLCO Cancer Screening Trial |
Robert Shoemaker |
National Cancer Institute |
PLCO |
Jun 12, 2023 |
2023-0063 |
| Environmental and Metabolic Phenotyping of the Blood Cancer Exposome |
Douglas Walker |
Emory University |
PLCO |
Jun 12, 2023 |
2023-0062 |
| Quantifying the proteome: exploratory associations with hepatocellular carcinoma |
Eleanor Watts |
Eleanor L. Watts |
PLCO |
Jun 12, 2023 |
2023-0061 |
| Characterizing the role of disruptive changes in native stromal architecture and cell composition in the etiopathogenesis and natural history of multi-state colorectal and prostate cancers |
Mustapha Abubakar |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA |
PLCO |
Jun 12, 2023 |
2023-0058 |
| Validation of Pathways-Based Biomarkers for the Early Detection of Prediagnostic Pancreatic Adenocarcinoma in the Blood |
Seetharaman Balasenthil |
The University of Texas M. D. Anderson Cancer Center |
PLCO |
Jun 12, 2023 |
2023-0056 |
| Ceramides as drivers of metabolic dysfunction and colorectal cancer risk |
Mary Playdon |
University of Utah and Huntsman Cancer Institute |
PLCO |
Jun 12, 2023 |
2023-0050 |
| Competing risks model with application to lung cancer and breast cancer in PLCO |
Minjung Lee |
Kangwon National University |
PLCO |
Jun 6, 2023 |
PLCO-1248 |
| Survival Curves for Hierarchical Data |
Ali Parsaee |
University of Alberta |
PLCO |
May 30, 2023 |
PLCO-1241 |
| Two-phase designs with failure time processes subject to non-susceptibility |
Li Cheung |
Li Chien Cheung |
PLCO |
May 30, 2023 |
PLCO-1238 |
| Association of HLA Diversity With All-Cause Mortality in PLCO |
Zhiwei Liu |
National Cancer Institute |
PLCO |
May 30, 2023 |
PLCO-1227 |
| Absolute risk from nested case-control data |
Mitchell Gail |
National Cancer Institute, National Institutes of Health |
PLCO |
May 5, 2023 |
PLCO-1218 |
| Identification of genetic and lifestyle determinants of estrogen metabolism profiles |
Fangcheng Yuan |
Vanderbilt University Medical Center |
PLCO |
Apr 19, 2023 |
PLCO-1199 |
| Developing an Accurate and Interpretable Risk-Based Model for Lung Cancer Screening |
Yi Luo |
Moffitt Cancer Center |
PLCO |
Apr 19, 2023 |
PLCO-1205 |
| Methods study for number of controls per case to choose in GWAS |
Hormuzd Katki |
NCI |
PLCO |
Apr 13, 2023 |
PLCO-1200 |
| Imbalanced Learning on Cancer Datasets |
Weitong Huang |
Australian National University |
PLCO |
Mar 29, 2023 |
PLCO-1189 |
| The influence of ovarian cancer treatment and treatment related complications on patients’ overall survival |
Kaja Michalczyk |
Pomeranian Medical University |
PLCO |
Mar 29, 2023 |
PLCO-1187 |
| Quantifying cancer screening overdiagnosis using synthetic excess incidence |
Stuart Baker |
National Cancer Institute |
PLCO |
Mar 20, 2023 |
PLCO-1178 |
| Genome-Wide Association Study of Circulating Estradiol in Postmenopausal Women |
Neil Murphy |
International Agency for Research on Cancer |
PLCO |
Mar 8, 2023 |
PLCO-1170 |
